384 related articles for article (PubMed ID: 11341845)
41. Development of a Förster resonance energy transfer assay for monitoring bacterial collagenase triple-helical peptidase activity.
Tokmina-Roszyk M; Tokmina-Roszyk D; Bhowmick M; Fields GB
Anal Biochem; 2014 May; 453():61-9. PubMed ID: 24608089
[TBL] [Abstract][Full Text] [Related]
42. Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.
Lauer-Fields J; Brew K; Whitehead JK; Li S; Hammer RP; Fields GB
J Am Chem Soc; 2007 Aug; 129(34):10408-17. PubMed ID: 17672455
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.
Del Nery E; Chagas JR; Juliano MA; Prado ES; Juliano L
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):233-8. PubMed ID: 7492318
[TBL] [Abstract][Full Text] [Related]
44. Design and synthesis of heterotrimeric collagen peptides with a built-in cystine-knot. Models for collagen catabolism by matrix-metalloproteases.
Ottl J; Battistuta R; Pieper M; Tschesche H; Bode W; Kühn K; Moroder L
FEBS Lett; 1996 Nov; 398(1):31-6. PubMed ID: 8946948
[TBL] [Abstract][Full Text] [Related]
45. Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments.
Bini A; Wu D; Schnuer J; Kudryk BJ
Biochemistry; 1999 Oct; 38(42):13928-36. PubMed ID: 10529239
[TBL] [Abstract][Full Text] [Related]
46. pH- and temperature-dependence of functional modulation in metalloproteinases. A comparison between neutrophil collagenase and gelatinases A and B.
Fasciglione GF; Marini S; D'Alessio S; Politi V; Coletta M
Biophys J; 2000 Oct; 79(4):2138-49. PubMed ID: 11023917
[TBL] [Abstract][Full Text] [Related]
47. Characterization of new fluorogenic substrates for the rapid and sensitive assay of cathepsin E and cathepsin D.
Yasuda Y; Kageyama T; Akamine A; Shibata M; Kominami E; Uchiyama Y; Yamamoto K
J Biochem; 1999 Jun; 125(6):1137-43. PubMed ID: 10348917
[TBL] [Abstract][Full Text] [Related]
48. Using fluorogenic peptide substrates to assay matrix metalloproteinases.
Fields GB
Methods Mol Biol; 2010; 622():393-433. PubMed ID: 20135296
[TBL] [Abstract][Full Text] [Related]
49. Identification of specific hemopexin-like domain residues that facilitate matrix metalloproteinase collagenolytic activity.
Lauer-Fields JL; Chalmers MJ; Busby SA; Minond D; Griffin PR; Fields GB
J Biol Chem; 2009 Sep; 284(36):24017-24. PubMed ID: 19574232
[TBL] [Abstract][Full Text] [Related]
50. The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition.
Brandstetter H; Grams F; Glitz D; Lang A; Huber R; Bode W; Krell HW; Engh RA
J Biol Chem; 2001 May; 276(20):17405-12. PubMed ID: 11278347
[TBL] [Abstract][Full Text] [Related]
51. Highly sensitive intramolecularly quenched fluorogenic substrates for renin based on the combination of L-2-amino-3-(7-methoxy-4-coumaryl)propionic acid with 2,4-dinitrophenyl groups at various positions.
Paschalidou K; Neumann U; Gerhartz B; Tzougraki C
Biochem J; 2004 Sep; 382(Pt 3):1031-8. PubMed ID: 15233625
[TBL] [Abstract][Full Text] [Related]
52. Role of the S1' subsite glutamine 215 in activity and specificity of stromelysin-3 by site-directed mutagenesis.
Holtz B; Cuniasse P; Boulay A; Kannan R; Mucha A; Beau F; Basset P; Dive V
Biochemistry; 1999 Sep; 38(37):12174-9. PubMed ID: 10508422
[TBL] [Abstract][Full Text] [Related]
53. Continuously recording fluorescent assays optimized for five human matrix metalloproteinases.
Netzel-Arnett S; Mallya SK; Nagase H; Birkedal-Hansen H; Van Wart HE
Anal Biochem; 1991 May; 195(1):86-92. PubMed ID: 1888020
[TBL] [Abstract][Full Text] [Related]
54. Characterization of helical cleavages in type II collagen generated by matrixins.
Vankemmelbeke M; Dekeyser PM; Hollander AP; Buttle DJ; Demeester J
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):633-40. PubMed ID: 9480869
[TBL] [Abstract][Full Text] [Related]
55. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
Kolkenbrock H; Essers L; Ulbrich N; Will H
Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
[TBL] [Abstract][Full Text] [Related]
56. Substrate specificity of the human matrix metalloproteinase stromelysin and the development of continuous fluorometric assays.
Niedzwiecki L; Teahan J; Harrison RK; Stein RL
Biochemistry; 1992 Dec; 31(50):12618-23. PubMed ID: 1472498
[TBL] [Abstract][Full Text] [Related]
57. Defining requirements for collagenase cleavage in collagen type III using a bacterial collagen system.
Yu Z; Visse R; Inouye M; Nagase H; Brodsky B
J Biol Chem; 2012 Jun; 287(27):22988-97. PubMed ID: 22573319
[TBL] [Abstract][Full Text] [Related]
58. Application of N-carboxyalkyl peptides to the inhibition and affinity purification of the porcine matrix metalloproteinases collagenase, gelatinase, and stromelysin.
Stack MS; Emberts CG; Gray RD
Arch Biochem Biophys; 1991 Jun; 287(2):240-9. PubMed ID: 1654808
[TBL] [Abstract][Full Text] [Related]
59. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
Knight CG; Willenbrock F; Murphy G
FEBS Lett; 1992 Jan; 296(3):263-6. PubMed ID: 1537400
[TBL] [Abstract][Full Text] [Related]
60. Extensive simulations of the full-length matrix metalloproteinase-2 enzyme in a prereactive complex with a collagen triple-helical peptide.
Díaz N; Suárez D
Biochemistry; 2015 Feb; 54(5):1243-58. PubMed ID: 25600631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
